LIDIA VASQUEZ: Open Payments
NPI 1548441579 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 33 payments from 8 companies in 2025. Trend: 2023 $402 · 2024 $948 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 8 | $389 |
| AstraZeneca Pharmaceuticals LP | 6 | $272 |
| Ardelyx, Inc. | 11 | $246 |
| Vifor Pharma, Inc. | 2 | $102 |
| Fresenius USA Marketing, Inc. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Vafseo, LOKELMA, IBSRELA, XPHOZAH 30 MG, Veltassa, VELPHORO, Kerendia, ELLIPSYS VASCULAR ACCESS SYSTEM.
Industry payments across CA — which companies pay providers there.
